|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample analysis, complaint and lot history review, applicable manufacture records, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leak in the needle housing was unconfirmed as the complaint could not be reproduced.The product returned for evaluation was (qty 2) 20 g x 1¿ w/y-site powerloc max infusion sets.Blood residue was seen within the tubing and needle housing, indicating use.None of these residue traces indicated a pathway for fluid to the exterior of the needle housing.Both samples were subsequently functionally tested for leakage by forceful infusion with a laboratory syringe and water combination, and neither device exhibited leakage through the system.A complaint history review found no potentially similar complaints for this product lot, and a review of the manufacture production records found no potentially related observations during production.The reported complaint issue will be included as part of ongoing trending and monitoring for potentially similar events.
|